Charles River Laboratories International (CRL) Gains from Sales and Divestitures (2011)
Charles River Laboratories International (CRL) posted quarterly Gains from Sales and Divestitures of $295457.0 for Q3 2011, up 1.2% on a QoQ basis from $291942.0 in Q2 2011.
Charles River Laboratories International (CRL) Gains from Sales and Divestitures (2011) Analysis & Trends
Charles River Laboratories International (CRL) has reported Gains from Sales and Divestitures for 1 consecutive years, with $295457.0 the latest figure, recorded in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Charles River Laboratories International | 11.36 Bn | 11.15 Bn | 744.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 24, 2011 | 295,457.00 |
| Sep 24, 2011 | 295,457.00 |
| Jun 25, 2011 | 291,942.00 |
| Jun 25, 2011 | 291,942.00 |